Evaluating the Impact of Medication Risk Mitigation Services in Medically Complex Older Adults

Jin, Hubert; Yang, Sue; Bankes, David; Finnel, Stephanie; Turgeon, Jacques; Stein, Alan

doi:10.3390/healthcare10030551

Cited by 2 publications

(1 citation statement)

References 35 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…This score exists on a continuous scale with higher scores being associated with adverse events, healthcare related costs, emergency room visits, falls, and mortality [57][58][59]. Furthermore, use of the MedWise Risk Score as part of medication risk mitigation services may significantly reduce healthcare costs related to emergency room visits, hospital admissions, and skilled nursing visits for organizations providing services for older adults that require nursing facility level care [60].…”

Section: Medwise Risk Scorementioning

confidence: 99%

Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization

Almodóvar¹,

Nahata

2022

Pharmaceuticals

View full text Add to dashboard Cite

The management of multiple chronic health conditions often requires patients to be exposed to polypharmacy to improve their health and enhance their quality of life. However, exposure to polypharmacy has been associated with an increased risk for adverse effects, drug-drug interactions, inappropriate prescribing, medication nonadherence, increased healthcare utilization such as emergency department visits and hospitalizations, and costs. Medication-based risk scores have been utilized to identify patients who may benefit from deprescribing interventions and reduce rates of inappropriate prescribing. These risk scores may also be utilized to prompt targeted discussions between patients and providers regarding medications or medication classes contributing to an individual’s risk for harm, eventually leading to the deprescribing of the offending medication(s). This opinion will describe existing medication-based risk scores in the literature, their utility in identifying patients at risk for specific adverse events, and how they may be incorporated in healthcare settings to reduce rates of potentially inappropriate polypharmacy and avoidable healthcare utilization and costs.

show abstract